STAT3 and hepatocellular carcinoma: However, rhIL-24 treatment significantly attenuated phosphorylated STAT3 levels in HCC-1954 cells (Fig. 6F), suggesting IL-24’s anticancer activity, at least in part, may result from dampening the STAT3 signaling axis.